Compound Muji Granules enhances cisplatin efficacy against alpha-fetoprotein-producing gastric cancer by suppressing epidermal growth factor receptor signaling

Figure 3 Gene expression results. A: Relative expression levels detected by quantitative real-time reverse transcription polymerase chain reaction; B: Quantitative analysis of protein expression levels based on densitometric analysis of western blot bands; C: Representative western blot bands. ^aP < 0.05. ^bP < 0.01. ^cP < 0.001. CMG: Compound Muji Granules; DPP: Cisplatin; EGFR: Epidermal growth factor receptor; mTOR: Mammalian target of rapamycin; p-AKT1: Phosphorylated-AKT1; p-mTOR: Phosphorylated-mammalian target of rapamycin; p-PIK3R1: Phosphorylated-PIK3R1.